New Leaf Venture Partners, L.L.C. Arvinas, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $44.5 Million
- Q1 2025
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Arvinas, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 1,585,721 shares of ARVN stock, worth $11.8 Million. This represents 25.03% of its overall portfolio holdings.
Number of Shares
1,585,721
Previous 1,585,721
-0.0%
Holding current value
$11.8 Million
Previous $30.4 Million
63.38%
% of portfolio
25.03%
Previous 40.97%
Shares
6 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$62.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$46.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$28.8 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$28.5 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$24.8 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $396M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...